Home › Research › Topics › metabolic-syndrome
metabolic-syndrome
304 studies tagged metabolic-syndrome, dated 1984-04-01 to 2026-10-26. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Interventions for Cognitive Impairment in Type 2 Diabetes Mellitus: An Umbrella Review of Pharmacological and Lifestyle Strategies, Mechanisms, and Clinical Implications 2026-10-26
- Visit-to-Visit Blood Pressure Variability, Glycemic Status and the Risk of Dementia, Stroke, and All-Cause Mortality: A UK Biobank Cohort Study 2026-10-13
- Plasma metabolomic profiling of frailty in older adults at risk of dementia 2026-10-08
Studies
304 studies carry this tag.
Date range
1984 to 2026
Top journals
- Journal of Alzheimer's disease : JAD 21
- medRxiv 16
- Alzheimer's & dementia : the journal of the Alzheimer's Association 14
- Neurology 10
- Nutrients 10
164 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The grey matter of the brain contains high levels of the essential nutrient DHA.
-
Lower RBC DHA levels are associated with smaller brain volumes and a "vascular" pattern of cognitive impairment even in persons free of clinical dementia.
-
Low serum vitamin B12 levels are associated with neurodegenerative disease and cognitive impairment.
-
During the last 2 decades, evidence has accumulated that a high cholesterol level may increase the risk of developing Alzheimer disease (AD).
-
Currently, insufficient evidence exists to draw firm conclusions on the association of any modifiable factors with risk of AD.
-
Twenty-four week supplementation with 900 mg/d DHA improved learning and memory function in ARCD and is a beneficial supplement that supports cognitive health with aging.
-
Promoting successful cognitive aging is a topic of major importance to individuals and the field of public health.
-
Risk of overall dementia and its subtypes was not associated with MetS or any MetS component in participants younger than 75.
-
To examine the relationship between smoking and Alzheimer's disease (AD) after controlling for study design, quality, secular trend, and tobacco industry affiliation of the authors, electronic databases were searched; 43 individual studies met the inclusion criteria.
-
36/100
Dementia is a complex human disease. The incidence of dementia among the elderly population is rising rapidly worldwide.
-
Observational studies have given conflicting results about the effect of statins in preventing dementia and cognitive decline.
-
Studies of the association of high blood pressure (BP) with dementia are not consistent.
-
The participants comprising the AIBL cohort represent a group of highly motivated and well-characterized individuals who represent a unique resource for the study of AD.
-
Obesity and diabetes significantly and independently increase risk for AD.
-
In the general population, the use of statins, but not of non-statin cholesterol-lowering drugs, was associated with a lower risk of AD compared with never use of cholesterol-lowering drugs.
-
Greater adherence to a Mediterranean diet is associated with a significant improvement in health status, as seen by a significant reduction in overall mortality (9%), mortality from cardiovascular diseases (9%), incidence of or mortality from cancer (6%), and incidence of Parkinson's disease and Alzheimer's disease (13%).
-
The mean age of the participants was 70 years, and 55% were male.
-
Alzheimer's disease, AD, is the most common form of dementia.
-
45/100
Alzheimer's disease (AD) is increasing in prevalence.
-
These findings demonstrate an association between antecedent statin use and neurofibrillary tangle burden at autopsy.
-
No association was found between MeSy and prevalent dementia.
-
Higher spontaneous production of interleukin 1 or tumor necrosis factor alpha by peripheral blood mononuclear cells may be a marker of future risk of Alzheimer disease (AD) in older individuals.
-
Higher adherence to the MeDi was associated with lower risk for AD (odds ratio, 0.76; 95% confidence interval, 0.67-0.87; P<.001).
-
More specifically, the full genetic potential of the child for physical growth ad mental development may be compromised due to deficiency (even subclinical) of micronutrients.
-
The essential fatty acids (EFAs), particularly the n-3 long-chain polyunsaturated fatty acids (LCPs), are important for brain development during both the fetal and postnatal period.
-
Substantial progress has been made in the understanding of the neurobiology of dementias, but comprehensive causal models are not available.
-
Fish consumption may be associated with slower cognitive decline with age.
-
Our results showed a relationship between arterial stiffness and cognitive impairment, suggesting that functional changes of the arterial system could be involved in the onset of dementia (VaD or AD types).
-
In this cohort study, statin therapy was not associated with a decreased risk of dementia.
-
The present review integrates findings of published studies that have evaluated the cognitive function of treated and untreated type 2 diabetic patients and provides a detailed overview of the neuropsychological assessments conducted.
-
Participants who drank no alcohol at midlife and those who drank alcohol frequently were both twice as likely to have mild cognitive impairment in old age as those participants who drank alcohol infrequently.
-
This double-blind randomized trial does not support the hypothesis that the use of soy protein supplement containing isoflavones improves cognitive function, bone mineral density, or plasma lipids in healthy postmenopausal women when started at the age of 60 years or later.
-
High homocysteine levels were not associated with AD and were not related to a decrease in memory scores over time.
-
Diabetes mellitus may be associated with an increased risk of developing AD and may affect cognitive systems differentially.
-
We found a weak relation between non-HDL-C, LDL-C, and HDL-C levels and the risk of VaD.
-
To address this, we first examined the prevalence of type 2 diabetes in a community-based controlled study, the Mayo Clinic Alzheimer Disease Patient Registry (ADPR), which follows patients with Alzheimer disease versus control subjects without Alzheimer disease.
-
Diagnosis of AD was associated inversely with FTI by itself and after adjustments for age, education, smoking status, body mass index, diabetes, any cancer diagnoses, and hormone supplements.
-
Hypertension is a risk factor for stroke, ischemic white matter lesions, silent infarcts, general atherosclerosis, myocardial infarction and cardiovascular morbidity and mortality.
-
Despite the crucial role played by cholesterol and copper in nutrition and normal brain function, recent evidence indicates that they may both be important factors in the etiology of Alzheimer's disease (AD).
-
Current literature is conflicting with regard to the effects of statins on memory loss.
-
After a mean follow-up of 3.9 years, 131 persons developed Alzheimer disease.
-
Both low diastolic and high systolic pressure are associated with an increased risk of Alzheimer disease and dementia in this elderly population.
-
After exclusion of the participants who had subsequently refused the medical interview, the 3C Study sample consisted of 3,649 men (39.3%) and 5,645 women, mean age 74.4 years, with a relatively high level of education and income.
-
In a randomized, placebo-controlled, double-blind study, we investigated whether statins alter cholesterol metabolites and reduce Abeta levels in the cerebrospinal fluid of 44 patients with Alzheimer's disease.
-
High LDL and total cholesterol levels are associated with cognitive impairment, and lowering these lipoprotein levels may be a strategy for preventing impairment.
-
After adjusting for age, race, and gender, persons with Alzheimer's disease and dementia associated with medical conditions were less likely to be diagnosed with hypertension, diabetes, congestive heart failure, and atrial fibrillation than were controls.
-
There is some evidence from recent observational studies that hyperhomocysteinemia is a risk factor for cognitive dysfunction, including Alzheimer's disease and vascular dementia.
-
We reviewed epidemiological and experimental studies of female gonadal hormone replacement therapy (HRT) on cognitive function in post-menopausal women and carried out meta-analyses.
-
46 (4.7%) subjects were classified as having probable or possible Alzheimer's disease.
-
Previous reports have suggested that estrogen replacement therapy (ERT) in women may exert a protective effect on their risk of developing Alzheimer's disease (AD).
From across this tag
10 of the 304 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- [Cognitive impairment in patients with cardiovascular risk: DECOG study]
- Metformin use and brain atrophy in nondemented elderly individuals with diabetes
- Randomized metformin and cognitive outcomes in the Diabetes Prevention Program Outcomes Study
- Brain vitamin D forms, cognitive decline, and neuropathology in community-dwelling older adults
- Adherence to the Mediterranean diet and incident frailty: Results from a longitudinal study
- Metabolic Syndrome and Cardiovascular Disease Impacts on the Pathophysiology and Phenotype of HIV-Associated Neurocognitive Disorders
- From Dementia to Eumentia: A New Approach to Dementia Prevention
- Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects
- Association of dietary and nutritional factors with cognitive decline, dementia, and depressive symptomatology in older individuals according to a neurogenesis-centred biological susceptibility to brain ageing
- Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention